Fundraising Fox
Autonomix Medical
NASDAQ: AMIXThe Woodlands, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Autonomix Medical
Sign up to find every way you can get introduced to Autonomix Medical
- Your email: who you already know at Autonomix Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Autonomix Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure. Its initial focus is interventional chronic pain management for pancreatic and other visceral cancer patients, with planned expansion across cardiology, pain management, pulmonology, and gastroenterology.
Founders & leadership
Autonomix Medical was founded in 2014 by David Robins, Robert Schwartz, and Landy Toth.
Board
Investors · 1
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 4 rounds · 2014–2023
▶$2.4MraisedJun 2023 · 27 investors · Other Health CareRule 506(b)
- Jonathan FosterDirector
- David RobinsDirector
- Matthew LourieExecutive Officer
- Walter KlempDirector
- Robert SchwartzExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.4M
- Minimum investment
- $10K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$675KraisedMar 2023 · 5 investors · Other Health CareRule 506(b)
- Robert SchwartzExecutive Officer
- Jonathan FosterDirector
- David RobinsDirector
- Walter KlempDirector
- Matthew LourieExecutive Officer
- Offering amount
- $675K
- Amount sold
- $675K
- Minimum investment
- $25K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2022 · 33 investors · Other Health CareRule 506(b)
- Walter KlempDirector
- Jonathan FosterDirector
- David RobinsDirector
- Robert SchwartzExecutive Officer
- Matt LourieExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $20K
- Finders' fees
- $92K
- Placement agents
- Falcon Capital Partners Limited
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedSep 2014 · 4 investors · Other Health CareRule 506(b)
- Robert Van TasselExecutive Officer
- Robert SchwartzExecutive Officer, Director
- Renee MasiDirector
- David RobinsExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Autonomix Medical do?
- Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure. Its initial focus is interventional chronic pain management for pancreatic and other visceral cancer patients, with planned expansion across cardiology, pain management, pulmonology, and gastroenterology.
- Who founded Autonomix Medical?
- Autonomix Medical was founded by David Robins, Robert Schwartz, Landy Toth in 2014.
- Who are Autonomix Medical's investors?
- Autonomix Medical's investors include BioStar Ventures.
- How much funding has Autonomix Medical raised?
- Autonomix Medical has disclosed $8.9M raised across 4 rounds.
- Where is Autonomix Medical headquartered?
- Autonomix Medical is headquartered in The Woodlands, US.